New targets for anti-angiogenesis drugs revealed

A new study describes a novel pathway of angiogenesis, the growth of new blood vessels. Targeting the new pathway, scientists identified two approaches that significantly reduced angiogenesis in mice. These discoveries may lead to novel treatments for diseases caused by excessive angiogenesis, including corneal graft rejection, age-related macular degeneration, cancer and diabetes.

Full Story →